Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Assay for inhibitors of nucleoside transport based upon the use of 5-(/sup 125/I)IODO-2'-deoxyuridine (IdUrd) as permeant

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:5326789
/sup 125/IdUrd has been shown to permeate human erythrocytes via the same carrier that transports physiological nucleosides. Like Urd and dThd, IdUrd was metabolically inert in the erythrocytes. Initial velocities (20/sup 0/C) of /sup 125/IdUrd transport were linear for approx.2s, yielding a K/sub m of 73 +/- 18 ..mu..M (n = 6). Ado inhibited /sup 125/IdUrd transport competitively with a K/sub i/ of 32 +/- 2 ..mu..M (n = 2). Submicromolar concentrations of high-affinity inhibitors of nucleoside transport, such as 6-((4-nitro-benzyl) thio)-9-..beta..-D-ribofuranosylpurine (NBMPR), dilazep and dipyridamole, blocked /sup 125/IdUrd transport. However, this activity of NBMPR could not be characterized by steady-state kinetics due to nonlinear initial velocities observed when /sup 125/IdUrd and NBMPR were added simultaneously to the cells. For this reason, high-affinity inhibitors were characterized in terms of their 50% inhibitory concentrations towards /sup 125/IdUrd transport: NBMPR 24 nM; dilazep, 88 nM; dipyridamole, 480 nM. The use of /sup 125/IdUrd as inhibitors of nucleoside transport by allowing the cell pellets generated in these assays to be counted directly in a gamma spectrometer, thereby circumventing the solubilization and decolorization of cell pellets required by assays that use /sup 3/H- or /sup 14/C-labeled nucleoside permeants.
Research Organization:
Wellcome Research Labs., Research Triangle Park, NC
OSTI ID:
5326789
Report Number(s):
CONF-8604222-
Conference Information:
Journal Name: Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) Journal Volume: 45:3
Country of Publication:
United States
Language:
English